INNOVATE Corp., through its subsidiaries, provides construction, insurance, life sciences, broadcasting, and other services in the United States, the United Kingdom, and internationally. The company models, details, fabricates, and erects structural steel for commercial and industrial, and infrastructure construction projects, including building and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, and power plants. It also fabricates trusses and girders; and fabricates and erects water pipes, water storage tanks, pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and various customized products. In addition, the company provides equipment for the oil and gas industry. Further, it offers long-term care, life, annuity, and other accident and health coverage; focuses on developing products for early osteoarthritis of the knee, as well as skin lightening technology; and operates over-the-air broadcasting stations and Azteca America, a Spanish-language broadcast network. The company was formerly known as HC2 Holdings, Inc. and changed its name to INNOVATE Corp. in September 2021. INNOVATE Corp. was founded in 1994 and is headquartered in New York, New York.
IPO Year:
Exchange: NYSE
Website: innovatecorp.com
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
PHOENIX, May 23, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE:VATE), announced today that it will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025 to DBMG's stockholders of record at the close of business on June 2, 2025. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients through a highly collaborative portfolio of companies which provide better designs, more efficient construction, and superior asset management solutions. The Company offers integrated steel constructio
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025 to DBMG's stockholders of record at the close of business on June 2, 2025. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $5 million of the total $5.5 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend. About INNOVATEINNOVATE Corp. is a portfolio of be
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that DBM Global Inc. ("DBMG"), has entered into an amended and restated credit agreement that provides for an $85 million term loan and a $135 million revolving credit facility (the "Credit Facility"), which will be used to fully repay DBMG's existing debt obligations and provide additional working capital capacity. The Credit Facility from a syndicate led by UMB Bank, N.A. provides for senior secured debt in the total amount of $220 million and is set to mature on May 20, 2030. The facility also contains an accordion feature to increase the allowable size of the credit fac
PHOENIX, May 20, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBMG"), announced today that it has entered into an amended and restated credit agreement that provides for an $85 million term loan and a $135 million revolving credit facility (the "Credit Facility"), which will be used to fully repay DBMG's existing debt obligations and provide additional working capital capacity. The Credit Facility from a syndicate led by UMB Bank, N.A. provides for senior secured debt in the total amount of $220 million and is set to mature on May 20, 2030. The facility also contains an accordion feature to increase the allowable size of the credit facility by an additional $50 million. "We are excited
- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share amounts)Three Months Ended March 31, 2025 2024 Increase / (Decrease)Revenue$274.2 $315.2 (13.0)%Net loss attributable to common stockholders and participating preferred stockholders$(24.8) $(
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "Investor
- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") system received FDA approval to assess kidney function -- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the fourth quarter. Financial Summary (in millions, except per share amounts)Three Months Ended December 31, Year Ended December 31, 2024 2023 Increase / (Decrease) 2024 2023 Increase / (Decrease)Revenue$236.6 $361.0
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.The Clinical Kidney Journal in February published MediBeacon study results on measured GFR (mGFR) using relmapirazin versus estimated GFR (eGFR) for the purpose of classifying patient Chronic Kidney Disease (CKD) stages.MediBeacon TGFR study results have been posted online in the February ahead of print section in the Journal of the American Society of Nephrology (JASN). NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today the National Medical Products Administration (NM
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicityMore than 800 million people have Chronic Kidney Disease (CKD), one of the world's leading causes of mortality worldwide, with associated deaths increasing over the past two decades1 NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that the U.S. Food and Drug Administration (FDA) has approved the MediBeacon®
8-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
10-Q - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
DEFA14A - INNOVATE Corp. (0001006837) (Filer)
DEF 14A - INNOVATE Corp. (0001006837) (Filer)
10-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per
Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/
NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE
NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Brian Goldstein to fill a vacancy on the INNOVATE Board of Directors, effective immediately. "The addition of Brian strengthens INNOVATE's Board, bringing tax expertise and a unique perspective that will help guide the Company as we strive to optimize our best-in-class assets across our three segments – Infrastructure, Life Sciences and Spectrum – and drive long-term value for our stakeholders," said Avie Glazer, Chairman of INNOVATE. "Brian has been a valuable member of the Board at DBM Global in our Infrastructure segment, and we are confident his dee
- Appoints Two New Directors - Brian Goldstein and Holly Cindell PHOENIX, Oct. 28, 2021 (GLOBE NEWSWIRE) -- DBM Global Inc. announced today the election of two new Board members – Brian Goldstein and Holly Cindell. Current Directors James R. Roach, Michael R. Hill, Robert V. Leffler, Jr., Kenneth S. Courtis, and Wayne Barr, Jr. will also continue their service on the Board. "The DBMG Board is excited to welcome Brian Goldstein, a former partner with PWC, and Holly Cindell, a construction industry veteran, to the Board. We believe that the experience of Brian and Holly will serve to enhance shareholder value in light of our continued expansion this last year," commented Chairman of th
PHOENIX, May 23, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE:VATE), announced today that it will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025 to DBMG's stockholders of record at the close of business on June 2, 2025. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients through a highly collaborative portfolio of companies which provide better designs, more efficient construction, and superior asset management solutions. The Company offers integrated steel constructio
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025 to DBMG's stockholders of record at the close of business on June 2, 2025. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $5 million of the total $5.5 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend. About INNOVATEINNOVATE Corp. is a portfolio of be
- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share amounts)Three Months Ended March 31, 2025 2024 Increase / (Decrease)Revenue$274.2 $315.2 (13.0)%Net loss attributable to common stockholders and participating preferred stockholders$(24.8) $(
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "Investor
- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") system received FDA approval to assess kidney function -- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the fourth quarter. Financial Summary (in millions, except per share amounts)Three Months Ended December 31, Year Ended December 31, 2024 2023 Increase / (Decrease) 2024 2023 Increase / (Decrease)Revenue$236.6 $361.0
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go
- Infrastructure: DBM Global third quarter revenue of $232.8 million -- Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter -- Spectrum: Broadcasting's delivered another quarter of strong growth driven by network launches - NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the third quarter. Financial Summary (in millions, except per share amounts)Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 Increase / (Decrease) 2024 2023 Increase / (Decrease)Revenue$242.2 $375.3 (35.5)% $870.5 $1,062.0 (18.0)%
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "In
- Infrastructure: DBM Global achieved second quarter revenue of $305.2 million -- Life Sciences: R2 achieved record Glacial system sales in North America in the second quarter -- Spectrum: Broadcasting's growth driven by launch of new networks and cost-cutting efforts - NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the second quarter. Financial Summary (in millions, except per share amounts)Three Months Ended June 30, Six Months Ended June 30, 2024 2023 Increase / (Decrease) 2024 2023 Increase / (Decrease)Revenue$313.1 $368.8 (15.1)% $628.3 $686.7 (8.5)%Net income (loss) attribu
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the second quarter 2024 on Wednesday, August 7, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "Inv
SC 13G/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)
SC 13G/A - INNOVATE Corp. (0001006837) (Subject)
SC 13G/A - INNOVATE Corp. (0001006837) (Subject)